About Pharmeco Group

Russian pharmaceutical, biologics and consumer healthcare group.

Established in 2001
Sales: more than USD 500 M
Employed: more than 1100 people

The Group operates in 4 main areas:
1) Research & Development (Biomaterials and biotechnology, aptamers, Nano-platforms);
2) Drugs Manufacturing (Fill & Finish, Primary & secondary packaging);
3) Market access, Sales & Distribution (Hospital/specialty care, Pharmacies, Medical equipment & laboratory diagnostics);
4) Construction & Equipping (Construction and equipping of social infrastructure facilities (institutions, hospitals & clinics).

Group's main advantages:
- Technology transfer, localization of foreign manufacturing on the territory of Russia
- Focus on hospital and reimbursement segment
- Five (5) GMP compliant manufacturing sites (Moscow, Ryazan, Podolsk, Novosibirsk)
- Warehouses with efficient logistics and distribution in compliance with GDP/GSP
- R&D of local drugs, including with cooperation with international companies and universities
- Long-term experience in the field of launch and sales of innovative products

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
1-й Нагатинский проезд, д.10 секция 1, Коломенский проезд, д. 13А, Москва, RU
description icon
Founded
2001
description icon
Keywords
Distribution Of Medicines, R&D Of Novel Drugs, Social Infrastructure Construction, State-Of-Art Manufacturing

Pharmeco Group Alternatives

Frequently Asked Questions about Pharmeco Group

Who is the CEO of Pharmeco Group?

Lyubov Egorova is the CEO of Pharmeco Group.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more